Searchable abstracts of presentations at key conferences in endocrinology

ea0056ep141 | Reproductive Endocrinology | ECE2018

Differences in the use of contraception between Roma and non-Roma women in Hungary

Vanya Melinda , Juhasz Lajos , Parducz Laszlo

Objective: The purpose of this study was to investigate the contraceptive practice and sociodemographic determinants of employment of contraceptive methods among sexually active Roma and non-Roma women.Design and methods: This research included 133 Roma and 687 non-Roma women aged 18–26 from secondary schools Szeged. Women completed self-report questionnaires on sociodemographic characteristics, contraceptive practice and sexual activity between 201...

ea0037ep733 | Pituitary: clinical | ECE2015

Evaluation of GH secretion after stroke

Nemes Orsolya , Tarjanyi Zita , Szapary Laszlo , Ruzsa Beata , Bodis Beata , Bajnok Laszlo , Mezosi Emese

Objective: According to recent studies, impaired secretion of GH is a frequent finding after ischaemic stroke. The aim of our study was to compare various available GH stimulation tests in post-stroke patients.Design: Seventeen patients were included in the study (12 males; mean age: 60.5 years; mean BMI, 27.7 kg/m2) with a mean 19.6 (±7.3) months after stroke. For screening, glucagon and small dose (0.15 μg/kg) GHRH-arginine (sdGHRH...

ea0022p188 | Clinical case reports and clinical practice | ECE2010

Case report of Borrelia burgdorferi infection as a possible trigger of Riedel’s thyroiditis

Kovacs Gabor Laszlo , Szabolcs Istvan , Gorombey Zoltan , Kovacs Laszlo , Hubina Erika , Denes Judit , Goth Miklos

Background: The detectable levels of thyroid antibodies in patients suffering from Riedel’s chronic fibrosing thyroiditis (RT) suggest a link between RT and Hashimoto’s thyroiditis, but the pathogenesis of RT is not really known. Lyme disease is the most frequent tick-borne infection with variable manifestations in different organs caused by Borrelia burgdorferi (Bb).Case report: A 59-year-old woman presented in our outpatient clinic wit...

ea0022p241 | Clinical case reports and clinical practice | ECE2010

Macroprolactinoma after chronic buserelin treatment in patient with prostate cancer

Laszlo Ferenc A , Gervain Mihaly , Voros Erika , Molnar Andor H , Laszlo Ferenc

Twelve years following hemicolectomy for colon adenocarcinoma, a 75-year-old patient with prostate cancer was treated for 4 weeks with the antiandrogen nilutamide and then with the long-acting GnRH agonist buserelin. The serum testosterone and prostate-specific antigen (PSA) levels had decreased dramatically after 3 months of treatment. After 2 years of buserelin administration, the hormonal state was examined. Serum estradiol, testosterone, DHEA, DHEAS, FSH and LH levels prov...

ea0092ps3-26-06 | Thyroid hormone diagnostics 2 | ETA2023

Does hypoechogenicity, as a single variable in decision of FNA, offer similar sensitivity and specificity as the elaborate tirads in the 10-20 mm range of thyroid nodules for cancer detection?

Solymosi Tamas , Joop Bonnema Steen , Frasoldati Andrea , Hegedus Laszlo , Laszlo Jambor Dr , Karanyi Zsolt , Laszlo Kovacs Gabor , Papini Enrico , Rucz Karoly , Russ Gilles , Nagy Endre

Background: Widespread use of imaging has led to the detection of an increasing number of thyroid nodules. Thyroid societies have recommended the use of Thyroid Imaging, Reporting and Data System (TIRADS). However, there is a multitude of such risk stratification systems (RSS) for selecting thyroid nodules for FNA. They may be time consuming and consensus on thyroid nodule descriptors lacks. Also studies have suggested that operators’ experience may not be inferior to usi...

ea0081p525 | Adrenal and Cardiovascular Endocrinology | ECE2022

Characterization of angiotensin II-induced dual-specificity MAPK phosphatase gene expression changes in vascular smooth muscle cells

Gem Janka , Kovacs Kinga , Balla Andras , Hunyady Laszlo

Angiotensin II (AngII) is an octapeptide hormone, which participates in physiological and pathological mechanisms. AngII exerts a number of biological effects through the type 1 angiotensin II receptor (AT1R). One of the main targets of AngII are vascular smooth muscle and its stimulation activates numerous signaling pathways that cause contraction and could also result in gene expression changes in vascular smooth muscle cells (VSMCs). Next-generation sequencing (NGS) experim...

ea0089c26 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Pre-therapy Functional Imaging with MIBG and DOTATATE to Guide Radiopharmaceutical Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience

Mallak Nadine , Szidonya Laszlo , Pegna Guillaume , Pommier Rodney , Mittra Erik

Background: Since their FDA-approval in 2018, both Lu177-DOTATATE and I131-MIBG radiopharmaceutical therapies are available at our institution for the treatment of pheochromocytoma and paraganglioma (PPGL). Tumor uptake of the radiopharmaceutical on pre-therapy imaging is a requirement for treatment. Here, we describe our experience with pre-therapy imaging, and how it relates to the tumor genotype and the therapeutic choice.Methods: This is a retrospect...

ea0090p570 | Adrenal and Cardiovascular Endocrinology | ECE2023

An Unexpected Enzyme in Vascular Smooth Muscle Cells: Angiotensin II Upregulates Cholesterol-25-Hydroxylase Gene Expression

Bernadett Kovacs Kinga , Borbala Gem Janka , Balla Andras , Hunyady Laszlo

Angiotensin II (AngII) is a vasoactive peptide hormone and the effector of the renin-angiotensin-aldosterone system. It exerts its main physiological effects through type 1 angiotensin II receptor (AT1R), but it can also contribute to the development of cardiovascular diseases. Likewise, oxysterols such as 25-hydroxycholesterol (25-HC), the product of cholesterol-25-hydroxylase (CH25H), can have harmful effects on the vasculature since they affect vascular smooth muscle cells ...

ea0063p272 | Pituitary and Neuroendocrinology 1 | ECE2019

A retrospective study of 275 cases of pituitary intervention in south great plain region of Hungary

Kupai Krisztina , Fulop Bela , Tiszlavicz Laszlo , Valkusz Zsuzsanna

Objective: Tumors of the pituitary gland and sellar region, called pitiutary adenoma (PA) represent approximatly 10% of all central nervous system tumors. The characteristics of these tumors may vary from population to population.Aim: The aim of this retrospective study was to investigate and understand the clinicopathological characteristics, the invasiveness, tumor features and clinical symptoms of PA in adult patients at south great plain region of Hu...

ea0049ep1388 | Thyroid (non-cancer) | ECE2017

Neuroendocrine progression of medullary thyroid cancer – case report

Sepp Krisztian , Besenyi Zsuzsanna , Tiszlavicz Laszlo , Valkusz Zsuzsanna

: Thyroid cancers represent approximately 1% of new cancer diagnoses. Thyroid malignancies are divided into papillary carcinomas (80%), follicular carcinomas (10%), medullary carcinomas (5–10%), anaplastic carcinomas (1–2%) other rare tumours (primary thyroid lymphomas, primary thyroid sarcomas). The main therapeutic options are surgery (mainly total thyreoidectomy), radioiodine treatment (depending on the type and stage of the tumour), levothyroxine therapy (thyroid...